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Introduction
The human cytochrome P450 (CYP) enzymes metabolize endogenous and xenobiotic compounds to more water-soluble products that are easily eliminated from the body [1] .
CYP3A is the most abundant subfamily in the human liver and intestine, and plays a major role in metabolism of many therapeutic drugs and toxins [2] . One family isoform, CYP3A5, is highly polymorphic [3, 4] and this polymorphism often leads to marked differences in protein expression and catalytic activity [5] [6] [7] [8] [9] . The most frequent single-nucleotide polymorphism (SNP) 6986A>G (in intron 3, responsible for CYP3A5*3 allele) is known to be associated with defective alternative splicing, resulting in the formation of a truncated protein and extremely low enzymatic activity [8] . Thus, it is very important to detect the SNP and identify the allele genotype to obtain theoretical and practical information on CYP3A5 metabolic activity.
We have developed two kinds of polyacrylamide gel electrophoresis (PAGE)-based SNP detection methods, Zn
2+ -cyclen PAGE [10] [11] [12] [13] [14] and Zn 2+ -Phos-tag PAGE [15] [16] [17] . Regarding the Zn 2+ -cyclen-PAGE methodology, the principle is based on the thymine-recognizing property of Zn 2+ -cyclen (cyclen = 1,4,7,10-tetraazacyclododecane) in double-stranded DNA [18] [19] [20] . The procedure combined with a polymerase chain reaction (PCR)-based heteroduplexing method permits the visualization of heteroduplex bands on the PAGE gel and enables SNP screening. As for the Zn 2+ -Phos-tag-PAGE methodology, the principle is based on the difference in mobility of the phosphorylated and nonphosphorylated DNA fragments (in the same number of base pairs) on the phosphate-affinity-PAGE gel containing immobilized phosphate-binding tag molecules, polyacrylamide-bound dizinc(II) complexes, Zn 2+ -Phos-tag (Phos-tag = 1,3-bis[bis(pyridin-2-ylmethyl)amino]propan-2-olate) [21] [22] [23] [24] [25] [26] [27] .
The procedure combined with allele-specific PCR method using a 1:1 mixture of 5'-phosphate-labeled and non-labeled allele-specific primers permits the separation of the 5'-phosphate-labeled PCR product as a slower migration band from the non-labeled counterpart and enables the determination of genotype as heterozygote or homozygote.
Genotyping and mapping assay of single-nucleotide polymorphisms
In this study, we introduce a combination method of Zn 2+ -Phos-tag PAGE and Zn 2+ -cyclen PAGE, and discuss its resolving power for SNP genotyping and mapping. As the first practical example of using the combination method and human genomic DNA samples, we demonstrate reliable screening of polymorphisms containing the SNP of 6986A>G, responsible for the major phenotype of CYP3A5 activity.
Methods

Preparation of genomic DNA
Genomic DNA was extracted from saliva (1 mL) obtained from 19 unrelated healthy Japanese donors (7 males and 12 females) according to the standard spin procedure for isolation of genomic DNA from saliva and mouthwash using the QIAamp DNA Blood Mini 
Design of the primers and procedure of PCR for Zn 2+ -cyclen PAGE
A primer 1, 5'-CCATACCCCTAGTTGTACGACACA-3', and the same reverse primer were designed as described above (see Fig. 1 ). PCR for amplification of the target region (244 bp) was performed with the following reaction mixture: a 0.20 µM primer 1, a 0.20 µM reverse primer, the genomic DNA template (1 µL), dNTPs (each at 0.20 mM), 1.0 mM MgSO 4 , 0.10 U KOD-plus-DNA polymerase, and its special buffer in a volume of 20 µL.
After initial denaturation at 95 ˚C for 3 min, the PCR amplification was carried out for 30
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DNA sequence analysis
For checking the DNA sequence of all subjects, each remaining PCR reaction mixture (19.5 µL) prepared for the Zn 2+ -cyclen-PAGE analysis was used as a template after ethanol precipitation and directly sequenced on both DNA strands using the BigDye Terminator v3.0
Ready Reaction Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and the primer 1 or the reverse primer (see Fig. 1 ) as a probe of each strand. Sequencing products after ethanol precipitation were dissolved with 13 µL of Hi-Di Formamide (Applied Biosystems) and then applied onto an ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
Results
Genotyping of CYP3A5*1 or CYP3A5*3 allele using Zn 2+ -Phos-tag PAGE
To apply the Zn 2+ -Phos-tag-PAGE methodology for the genotyping of the SNP 6986A>G responsible for CYP3A5*3 allele, we first performed allele-specific amplifications of the target region of CYP3A5 (see Fig. 1 , a 128-bp sequence of 247062-247189 entered as GenBank Accession No. NG_000004.3) using a 1:1 mixture of 5'-phosphate-labeled CYP3A5*3-allele-specific and non-labeled CYP3A5*1-allele-specific primers, the reverse non-labeled primer, and each genomic template from 19 unrelated healthy Japanese subjects.
Subsequently, the resultant PCR products were analyzed using 20 µM Zn 2+ -Phos-tag PAGE. 
Genetic analysis using Zn 2+ -cyclen PAGE
Next, the 244-bp DNA sequence of 247062-247305 in CYP3A5 gene shown in Fig. 1 was amplified using each genomic template from the 19 subjects for the Zn 2+ -cyclen-PAGE analysis. We examined the zygosity (homo or hetero) using the resultant PCR products and compared with the results of the genotyping by the Zn 2+ -Phos-tag-PAGE methodology described above. The results of 5.0 mM Zn 2+ -cyclen PAGE are shown in Fig. 3 The appearance of multiple bands and a differential pattern in the individual with the *1/*1 homozygote (subject number 8) suggests the existence of another SNP.
DNA sequence analysis
To check the DNA sequence of all subjects, direct sequencing analyses were conducted using each of the PCR products prepared for the Zn 2+ -cyclen PAGE analysis. As for the SNP site of 6986A>G, typical sequencing data are shown in Fig. 2B . All concerns of the homozygosity and heterozygosity were consistent with the genotyping results by Zn 2+ -Phos-tag PAGE. The direct sequencing demonstrated that our genotyping assays for identification of CYP3A5*1 or CYP3A5*3 allele using the Zn 2+ -Phos-tag-PAGE methodology were complete. As for another SNP site in one individual (subject number 8), a heterozygous nucleotide substitution of 6929G>A was newly discovered (see the sequencing data in Fig. 3 and the asterisked site in Fig. 1 ). The direct sequencing disclosed no other variation in the sequence of all subjects, indicating that all heterozygous substitutions in CYP3A5 region tested were detected by our screening assays using the Zn 2+ -cyclen-PAGE methodology. All subjects containing the PCR product showing additional/other bands due to the novel SNP were confirmed by direct sequencing analyses for the sense and anti-sense strands.
Discussion
In this article, we described a combination method of Zn 2+ -Phos-tag PAGE and such as a single-strand conformation polymorphism and a denaturing gradient gel electrophoresis [11] . Since both electrophoretic methods using the DNA-binding zinc(II) complexes require a general PCR apparatus and a mini-slab PAGE system, it may be a very convenient tool for clinical researchers and physicians to obtain the theoretical and practical information on CYP3A5 activity from a small number of patients. One hundred mini-slab gels for Zn 2+ -Phos-tag-PAGE (20 µM Zn 2+ -Phos-tag, 1-mm-thick, 9-cm-wide, 9-cm-long gels) can be prepared from 10 mg of the commercially available Phos-tag acrylamide AAL-107 (see Methods section). The cost of Phos-tag acrylamide used per one gel is about 6 US dollars. Regarding the Zn 2+ -cyclen molecule, the cost for one electrophoresis run (in this case of 19 DNA fragments) is less than 1 US dollar [11] . In conclusion, we provided information regarding a new assay for allelic discrimination between the three different genotypes of the CYP3A5 (6986A>G). The gel-based assay using DNA-binding zinc(II) -11 -complexes was able to easily discriminate between all three genotypes in the population studied and even contributed to discover a novel SNP. Use of this strategy is thus worthy of consideration for an accurate analysis of SNP in a small-scale screening. Genotyping and mapping assay of single-nucleotide polymorphisms -18 - Fig. 2 
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